Kenji Imai

9PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersNanotoxicology, health and safetyBehavioural epidemiologyMedical biochemistry - amino acids and metabolitesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 15, 2026
Subcutaneous Adipose Tissue Accumulation is Associated With an Improved Prognosis in Patients With Hepatocellular Carcinoma.

Kenji Imai, Koji Takai, Mikita Oi

|Mar 21, 2026
Suppression of Indoleamine 2,3-Dioxygenase Enhances Immune Responses to the Therapeutic Vaccine for Chronic Hepatitis B.

Yohei Shirakami, Soranobu Ninomiya, Takayasu Ideta

|Mar 02, 2026
Frailty Diagnosed With the Clinical Frailty Scale Stratifies the Risk of Covert and Overt Hepatic Encephalopathy in Patients With Cirrhosis.

Shinji Unome, Takao Miwa, Sachiyo Hirata

|Feb 16, 2026
Letter: Amino Acid Imbalance and Mortality in Cirrhosis-Interpretation and Methodological Considerations. Authors' Reply.

Yuki Utakata, Takao Miwa, Shinji Unome

|Feb 08, 2026
Clinical Characteristics of Patients With Advanced Hepatocellular Carcinoma Who Transitioned to Subsequent Therapies Following Systemic Therapy.

Kenji Imai, Koji Takai, Masashi Aiba

|Jan 17, 2026
Response to "Excessive Visceral Adipose Tissue Accumulation Increases the Risk of Recurrence and Mortality After Curative Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma".

Kenji Imai, Koji Takai, Mikita Oi

Pageof 2

Frequent Collaborators

7 joint publications

Shinji Unome

7 joint publications

Takao Miwa

7 joint publications

Masahito Shimizu

6 joint publications

Yohei Shirakami